ATE361757T1 - Stabile fumagillin-formulierung - Google Patents

Stabile fumagillin-formulierung

Info

Publication number
ATE361757T1
ATE361757T1 AT00906438T AT00906438T ATE361757T1 AT E361757 T1 ATE361757 T1 AT E361757T1 AT 00906438 T AT00906438 T AT 00906438T AT 00906438 T AT00906438 T AT 00906438T AT E361757 T1 ATE361757 T1 AT E361757T1
Authority
AT
Austria
Prior art keywords
fumagillin
formulation
stable
treating
relates
Prior art date
Application number
AT00906438T
Other languages
English (en)
Inventor
Bernard Abramovici
Jean-Luc Dubois
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9902401A external-priority patent/FR2790200B3/fr
Priority claimed from FR9909702A external-priority patent/FR2796842B3/fr
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE361757T1 publication Critical patent/ATE361757T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT00906438T 1999-02-26 2000-02-21 Stabile fumagillin-formulierung ATE361757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9902401A FR2790200B3 (fr) 1999-02-26 1999-02-26 Formulation stable contenant de la fumagilline
FR9909702A FR2796842B3 (fr) 1999-07-27 1999-07-27 Formulation stable contenant de la fumagilline

Publications (1)

Publication Number Publication Date
ATE361757T1 true ATE361757T1 (de) 2007-06-15

Family

ID=26234836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906438T ATE361757T1 (de) 1999-02-26 2000-02-21 Stabile fumagillin-formulierung

Country Status (12)

Country Link
US (1) US6528539B1 (de)
EP (1) EP1156829B1 (de)
JP (1) JP2002537358A (de)
AT (1) ATE361757T1 (de)
AU (1) AU2811400A (de)
CY (1) CY1106807T1 (de)
DE (1) DE60034770T2 (de)
DK (1) DK1156829T3 (de)
ES (1) ES2286998T3 (de)
HU (1) HU228857B1 (de)
PT (1) PT1156829E (de)
WO (1) WO2000050084A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1427397E (pt) * 2001-09-10 2008-03-24 Hoffmann La Roche Formulações tixotrópicas oleosas
CA2549115C (en) * 2002-09-26 2013-07-16 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
CN101990441A (zh) * 2007-11-28 2011-03-23 默萨那治疗学股份有限公司 生物相容的生物可降解的烟曲霉素类似物轭合物
JP5873375B2 (ja) * 2012-04-03 2016-03-01 中日本カプセル 株式会社 ソフトカプセル及びソフトカプセルの製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918103A (en) * 1988-07-25 1990-04-17 Formulations Development Labs Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
DE69311278T2 (de) 1992-12-16 1997-10-30 Takeda Chemical Industries Ltd Stabile pharmazeutische Zubereitung mit Fumagillolderivaten
AP646A (en) 1995-03-27 1998-04-27 Sanofi Synthelabo Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections.
JPH1081621A (ja) * 1996-04-01 1998-03-31 Takeda Chem Ind Ltd 経口投与用医薬組成物
EP0799616A1 (de) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Orale Zubereitung enthaltend ein Fumagillolderivat
US20010025046A1 (en) * 1999-06-24 2001-09-27 Rong(Ron) Liu Self-emulsifying systems containing anticancer medicament
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions

Also Published As

Publication number Publication date
US6528539B1 (en) 2003-03-04
HU228857B1 (en) 2013-06-28
EP1156829A1 (de) 2001-11-28
EP1156829B1 (de) 2007-05-09
DE60034770D1 (de) 2007-06-21
JP2002537358A (ja) 2002-11-05
WO2000050084A1 (fr) 2000-08-31
CY1106807T1 (el) 2012-05-23
HUP0202151A2 (en) 2002-10-28
HUP0202151A3 (en) 2005-02-28
AU2811400A (en) 2000-09-14
PT1156829E (pt) 2007-08-17
DE60034770T2 (de) 2008-04-30
DK1156829T3 (da) 2007-09-10
ES2286998T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DE60135059D1 (de) Positionsabhängiges Chatsystem und Verfahren
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
DE60122196D1 (de) Synergistische antioxidans-kombination von delta tocols und polyphenolen
FI955315A7 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n ho itoon
FI972793L (fi) Nebivololin käyttö antiaterogeenisenä aineena
DE50214540D1 (de) Stanz bei der behandlung von wunden
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
AR034343A1 (es) Combinaciones farmaceuticas
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
EP1117431A4 (de) Behandlung von acidose
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
NO965260L (no) Benzopyraner og deres anvendelse som terapeutiske midler
EP1455858A4 (de) Katheterzusammensetzung und ihre verwendungen
DE60034770D1 (de) Stabile fumagillin-formulierung
DE60222664D1 (de) Hautbehandlungsmittel
DE60103685D1 (de) Behandlung von Poriomania
NO20032597D0 (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
BR0108980A (pt) Aplicação e formulação farmacêuticas compreendendo inibidor de reabsorção de norepinefrina
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
NO20013534D0 (no) Blodströmsforbedringsmidler og trombose-hemmere eller - remedier
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1156829

Country of ref document: EP